Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-27
DOI
10.1038/s41598-019-39427-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
- (2017) Toni Rose Jue et al. Journal of Translational Medicine
- Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2
- (2017) Danhua Zhu et al. Cancer Medicine
- Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma
- (2016) Sarah Maria Johler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53
- (2016) R. Fukaya et al. CANCER RESEARCH
- MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis
- (2016) A Ghoochani et al. ONCOGENE
- Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
- (2016) Balint Otvos et al. STEM CELLS
- New insights into acquired temozolomide resistance in glioblastoma?
- (2015) Caroline Happold et al. BRAIN
- Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo
- (2013) F. Hussain et al. MOLECULAR CANCER THERAPEUTICS
- Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner
- (2013) Jelena Põlajeva et al. Molecular Oncology
- The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients
- (2012) K.L. McDonald et al. EUROPEAN JOURNAL OF CANCER
- Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression
- (2011) Michel Mittelbronn et al. ACTA NEUROPATHOLOGICA
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells
- (2011) Nina Baron et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
- (2010) Gaspar J. Kitange et al. JOURNAL OF NEURO-ONCOLOGY
- Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
- (2010) Y. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-species comparisons of the pharmacokinetics of ibudilast
- (2009) L. M. Sanftner et al. XENOBIOTICA
- p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts
- (2008) E. B. Dinca et al. CANCER RESEARCH
- Role of Macrophage Migration Inhibition Factor in Kidney Disease
- (2008) Hui Y. Lan NEPHRON EXPERIMENTAL NEPHROLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started